Recombinant Hepatitis B Vaccine Market Will Exhibit an Impressive Expansion by 2024-2031

Recombinant hepatitis B vaccine market is expected to grow at a CAGR of 5.6% during the forecast. The rising incidence of acute and chronic hepatitis B infections across the globe is driving market growth. There is an increased demand for recombinant HBV vaccines 10mcg/ml and 10 mcg/0.5 ml, which provide long-lasting protection against chronic hepatitis B infection. The Hepatitis B vaccine is a preventative vaccine for hepatitis B. It's a shot that's administered to the arm or thigh. It works by causing the body to develop virus immunity.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/recombinant-hepatitis-b-vaccine-market

The increasing prevalence of chronic HBV infections, rising awareness about vaccination programs, and rising demand for preventive vaccines are some factors driving the global recombinant hepatitis B vaccine market. In addition, the vaccine manufacturers have been significantly focusing on the development of novel recombinant hepatitis B vaccines. North America is expected to hold a significant share in the market owing to the rising number of chronic HBV cases in the region. The Latin America recombinant hepatitis B vaccine market is driven by the rising focus on the prevention and treatment of HBV infection in the region. Further, owing to the rising incidence of HBV infections and growing awareness about vaccination programs in the region, Asia Pacific is expected to witness lucrative growth in the global recombinant hepatitis B vaccine market.

Global Recombinant Hepatitis B Vaccine Market Report by Segment

By Type

• 10mcg/ml
• 10mcg/0.5ml

By Application

• Newborn/Children
• Adult

A full report of Recombinant Hepatitis B Vaccine Market is available at: https://www.omrglobal.com/industry-reports/recombinant-hepatitis-b-vaccine-market

Recombinant Hepatitis B Vaccine Market- Segment by Region

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Bharat Biotech International Ltd.
• CSL Ltd.
• Dynavax Technologies Corp
• Emergent BioSolutions Inc.
• GlaxoSmithKline PLC
• KM Biologics (Meiji Holdings Co., Ltd.)
• LG Chem Ltd.
• Merck & Co., Inc.
• Novartis AG
• Pfizer, Inc.
• Sanofi S.A.
• Serum Institute of India Pvt. Ltd.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.